论文期刊

取消

高级检索

检索历史清除

首页> Gynecologic oncology> Cost-effectiveness of lenvatinib plus pembrolizumab versus chemotherapy for recurrent mismatch repair-proficient endometrial cancer after platinum-based therapy.

Cost-effectiveness of lenvatinib plus pembrolizumab versus chemotherapy for recurrent mismatch repair-proficient endometrial cancer after platinum-based therapy.

导出 LinkOut

翻译打印收藏纠错

作者： Shayan,Dioun ^[1] ; Ling,Chen ^[2] ; Alexandre Buckley,De Meritens ^[1] ; Caryn M,St Clair ^[1] ; June Y,Hou ^[1] ; Fady,Khoury-Collado ^[1] ; Tarah,Pua ^[1] ; Dawn L,Hershman ^[3] ; Jason D,Wright ^[4]

作者单位： Columbia University College of Physicians and Surgeons; Herbert Irving Comprehensive Cancer Center; New York Presbyterian Hospital. ^[1] Columbia University College of Physicians and Surgeons. ^[2] Columbia University College of Physicians and Surgeons; Joseph L. Mailman School of Public Health, Columbia University; Herbert Irving Comprehensive Cancer Center; New York Presbyterian Hospital. ^[3] Columbia University College of Physicians and Surgeons; Herbert Irving Comprehensive Cancer Center; New York Presbyterian Hospital. Electronic address: jw2459@columbia.edu. ^[4]

关键词 Endometrial cancer Immunotherapy Lenvatinib Pembrolizumab Uterine cancer

主题词女(雌)性(Female);人类(Humans);费用效益分析(Cost-Benefit Analysis);DNA错配修复(DNA Mismatch Repair);肿瘤复发, 局部(Neoplasm Recurrence, Local);子宫内膜肿瘤(Endometrial Neoplasms);抗肿瘤联合化疗方案(Antineoplastic Combined Chemotherapy Protocols);质量校正寿命(Quality-Adjusted Life Years);苯脲化合物(Phenylurea Compounds);喹啉类(Quinolines)

DOI 10.1016/j.ygyno.2023.12.027

PMID 38262241

发布时间 2024-08-12

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Gynecologic oncology

70-74页

相似文献

中文期刊
外文期刊
学位论文
会议论文

特别提示：本网站仅提供医学学术资源服务，不销售任何药品和器械，有关药品和器械的销售信息，请查阅其他网站。

客服热线：4000-115-888 转3 (周一至周五：8:00至17:00)
|
客服邮箱：yiyao@wanfangdata.com.cn

违法和不良信息举报电话：4000-115-888，举报邮箱：problem@wanfangdata.com.cn，举报专区

官方微信

万方医学小程序

关于我们网站地图知识产权

北京万方数据股份有限公司

万方数据电子出版社

京ICP证010071号

京公网安备11010802020237号

京ICP备08100800号-1

违法和不良信息举报电话：4000-115-888，举报邮箱：problem@wanfangdata.com.cn，举报专区

new翻译充值订阅收藏移动端

官方微信

万方医学小程序

调查问卷